Fresenius SE - 14 Year Stock Price History | FSNUY
Historical daily share price chart and data for Fresenius SE since 2011 adjusted for splits and dividends. The latest closing stock price for Fresenius SE as of May 02, 2025 is 12.00.
- The all-time high Fresenius SE stock closing price was 19.55 on June 19, 2017.
- The Fresenius SE 52-week high stock price is 12.10, which is 0.8% above the current share price.
- The Fresenius SE 52-week low stock price is 7.47, which is 37.8% below the current share price.
- The average Fresenius SE stock price for the last 52 weeks is 9.16.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Fresenius SE Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2025 |
10.2147 |
8.6030 |
12.0000 |
8.6030 |
12.0000 |
38.20% |
2024 |
8.0939 |
7.9400 |
9.5780 |
6.6240 |
8.6830 |
12.01% |
2023 |
7.2024 |
6.9091 |
8.3370 |
5.9742 |
7.7520 |
14.47% |
2022 |
7.3201 |
9.4268 |
10.1229 |
4.7008 |
6.7718 |
-28.46% |
2021 |
11.1184 |
10.8938 |
13.3078 |
8.8653 |
9.4663 |
-11.37% |
2020 |
10.5078 |
12.6596 |
12.6596 |
6.2050 |
10.6807 |
-16.10% |
2019 |
11.7608 |
10.8972 |
13.0834 |
10.0868 |
12.7301 |
18.22% |
2018 |
16.4284 |
17.0352 |
19.2943 |
9.8712 |
10.7683 |
-37.29% |
2017 |
17.8761 |
16.7245 |
19.5474 |
15.7765 |
17.1706 |
0.55% |
2016 |
15.7538 |
14.6134 |
17.8573 |
12.8676 |
17.0759 |
10.23% |
2015 |
13.9202 |
10.9749 |
16.1317 |
10.7698 |
15.4910 |
38.30% |
2014 |
10.8239 |
10.7135 |
11.8062 |
9.9875 |
11.2014 |
3.04% |
2013 |
8.8969 |
8.0535 |
10.8990 |
7.6413 |
10.8713 |
35.43% |
2012 |
7.5824 |
6.5761 |
8.7737 |
6.4009 |
8.0272 |
25.46% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.000B |
$23.628B |
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|